Nano-biomaterials for cardiovascular applications: Clinical perspective

J Control Release. 2016 May 10:229:23-36. doi: 10.1016/j.jconrel.2016.03.015. Epub 2016 Mar 15.

Abstract

Cardiovascular diseases, including ischemic heart disease and stroke, are responsible for nearly 25% of all deaths worldwide. Globally, their prevalence continues to increase, in spite of enormous progress in cardiovascular diagnostics and therapy. For therapeutic and regenerative purposes, biomaterials promise solutions with multiple advantages over synthetic materials. Furthermore, their easy availability as nanoformulations recommends their application as drug carriers or protective nanoshells improving the biocompatibility of imaging agents. In this work, we review the most promising and clinically meaningful scientific reports with regard to (nano)biomaterials with particular focus on potential improvements of existing, and development of novel constructs for cardiovascular applications.

Keywords: Biomaterials; Bioresorbable vascular stents; Cardiac patches; Cardiovascular tissue engineering; Drug delivery nanosystems; Vascular grafts.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials / therapeutic use*
  • Blood Vessel Prosthesis
  • Cardiovascular Diseases / diagnostic imaging
  • Cardiovascular Diseases / therapy*
  • Humans
  • Nanostructures / therapeutic use*
  • Regeneration
  • Stents
  • Tissue Engineering

Substances

  • Biocompatible Materials